Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL220360 (Mk-0364, Mk0364, MK-0364, MK-0634, Taranabant) |
---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
CB1 receptor/Cannabinoid CB1 receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL218] [GtoPdb: 56] [UniProtKB: P21554] | ||||||||
GtoPdb | Displacement of [3H]rimonabant from human CB1 receptor expressed in HEK293 cells by liquid scintillation counting. | - | 9.52 | pKi | 0.3 | nM | Ki | Bioorg Med Chem Lett (2009) 19: 4183-90 [PMID:19520572] |
ChEMBL | Displacement of [3H]rimonabant from human CB1 receptor expressed in HEK293 cells by liquid scintillation counting | B | 9.52 | pKi | 0.3 | nM | Ki | Bioorg Med Chem Lett (2009) 19: 4183-4190 [PMID:19520572] |
ChEMBL | Displacement of [3H]CP-55940 from human CB1R F170L mutant expressed in CHO cells | B | 7.66 | pIC50 | 22 | nM | IC50 | J Med Chem (2008) 51: 2108-2114 [PMID:18333607] |
ChEMBL | Displacement of [3H]SR-141716 from human CBR1 S383A mutant expressed in CHO cells | B | 7.72 | pIC50 | 19 | nM | IC50 | J Med Chem (2008) 51: 2108-2114 [PMID:18333607] |
ChEMBL | Displacement of [3H]CP-55940 from human CB1R F200L mutant expressed in CHO cells | B | 8.3 | pIC50 | 5 | nM | IC50 | J Med Chem (2008) 51: 2108-2114 [PMID:18333607] |
ChEMBL | Displacement of [3H]CP-55940 from human CB1R W279A mutant expressed in CHO cells | B | 8.31 | pIC50 | 4.9 | nM | IC50 | J Med Chem (2008) 51: 2108-2114 [PMID:18333607] |
ChEMBL | Displacement of [3H]CP-55940 from human CB1R K192L mutant expressed in CHO cells | B | 8.92 | pIC50 | 1.2 | nM | IC50 | J Med Chem (2008) 51: 2108-2114 [PMID:18333607] |
ChEMBL | Displacement of [3H]CP-55940 from human wild type CB1R expressed in CHO cells | B | 9.13 | pIC50 | 0.74 | nM | IC50 | J Med Chem (2008) 51: 2108-2114 [PMID:18333607] |
ChEMBL | Displacement of [3H]CP55490 from human recombinant cannabinoid CB1 receptor expressed in CHO cells | B | 9.13 | pIC50 | 0.74 | nM | IC50 | Bioorg Med Chem Lett (2010) 20: 4757-4761 [PMID:20643546] |
ChEMBL | Inhibition of radiolabeled CP5549 binding to human Cannabinoid receptor 1 expressed in CHO cells by competition assay | B | 9.52 | pIC50 | 0.3 | nM | IC50 | J Med Chem (2020) 63: 6276-6302 [PMID:31497963] |
ChEMBL | Displacement of [3H]CP-55940 from human recombinant CB1R expressed in CHO cells | B | 9.52 | pIC50 | 0.3 | nM | IC50 | J Med Chem (2007) 50: 3427-3430 [PMID:17608398] |
ChEMBL | Displacement of [3H]CP-55940 from human CB1R expressed in HEK293 cells | B | 9.52 | pIC50 | 0.3 | nM | IC50 | J Med Chem (2008) 51: 2115-2127 [PMID:18335976] |
ChEMBL | Inverse agonist activity at cannabinoid CB1 receptor | F | 9.52 | pIC50 | 0.3 | nM | IC50 | Bioorg Med Chem Lett (2009) 19: 2591-2594 [PMID:19328684] |
ChEMBL | Inhibition of CB1 receptor (unknown origin) | B | 9.52 | pIC50 | 0.3 | nM | IC50 | Medchemcomm (2013) 4: 631-652 |
ChEMBL | Inhibition of [3H]CP-55940 binding to human recombinant CB1 receptor in CHO cells | B | 9.52 | pIC50 | 0.3 | nM | IC50 | J Med Chem (2006) 49: 7584-7587 [PMID:17181138] |
ChEMBL | Displacement of [3H]CP-55940 from recombinant human CB1 receptor expressed in CHO cells | B | 9.52 | pIC50 | 0.3 | nM | IC50 | Bioorg Med Chem Lett (2009) 19: 5195-5199 [PMID:19632830] |
ChEMBL | Inhibition of human CB1 receptor | B | 9.52 | pIC50 | 0.3 | nM | IC50 | Bioorg Med Chem Lett (2010) 20: 1448-1452 [PMID:20096577] |
ChEMBL | Inhibition of cannabinoid CB1 receptor | B | 9.52 | pIC50 | 0.3 | nM | IC50 | J Med Chem (2010) 53: 4028-4037 [PMID:20423086] |
ChEMBL | Binding affinity to human CB1 receptor | B | 9.52 | pIC50 | 0.3 | nM | IC50 | Bioorg Med Chem Lett (2010) 20: 3750-3754 [PMID:20483606] |
ChEMBL | Displacement of [3H]CP-55940 from human CB1 receptor expressed in CHO cells | B | 9.54 | pIC50 | 0.29 | nM | IC50 | J Med Chem (2008) 51: 4359-4369 [PMID:18570365] |
ChEMBL | Displacement of [3H]SR-141716 from human wild type CB1R expressed in CHO cells | B | 10.03 | pIC50 | 0.09 | nM | IC50 | J Med Chem (2008) 51: 2108-2114 [PMID:18333607] |
ChEMBL | Inverse agonist activity at human recombinant CB1 receptor assessed as inhibition of forskolin-induced cAMP production in CHO cells | F | 8.62 | pEC50 | 2.4 | nM | EC50 | J Med Chem (2006) 49: 7584-7587 [PMID:17181138] |
ChEMBL | Inverse agonist activity at human CB1 receptor assessed as forskolin-induced cAMP level by adenylyl cyclase activation flash plate assay | F | 8.62 | pEC50 | 2.4 | nM | EC50 | Bioorg Med Chem Lett (2009) 19: 5195-5199 [PMID:19632830] |
CB1 receptor/Cannabinoid CB1 receptor in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3571] [GtoPdb: 56] [UniProtKB: P20272] | ||||||||
ChEMBL | Displacement of [3H]CP-55940 from CB1 receptor in Sprague-Dawley rat cerebellum by liquid scintillation spectrometry | B | 9.07 | pIC50 | 0.86 | nM | IC50 | J Med Chem (2008) 51: 7216-7233 [PMID:18954042] |
ChEMBL | Displacement of [3H]SR141716A from rat brain CB1 receptor at pH 7.4 after 1 hr by liquid scintillation counting | B | 9.52 | pIC50 | 0.3 | nM | IC50 | Bioorg Med Chem Lett (2011) 21: 4913-4918 [PMID:21741835] |
CB2 receptor/Cannabinoid CB2 receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL253] [GtoPdb: 57] [UniProtKB: P34972] | ||||||||
ChEMBL | Displacement of [3H]rimonabant from human CB2 receptor expressed in HEK293 cells by liquid scintillation counting | B | 6.54 | pKi | 290 | nM | Ki | Bioorg Med Chem Lett (2009) 19: 4183-4190 [PMID:19520572] |
GtoPdb | - | - | 6.54 | pKi | 290 | nM | Ki | Bioorg Med Chem Lett (2009) 19: 4183-90 [PMID:19520572] |
ChEMBL | Displacement of [3H]WIN-55212-2 from human CB2 receptor expressed in CHOK1 cells by liquid scintillation spectrometry | B | 5.93 | pIC50 | 1170 | nM | IC50 | J Med Chem (2008) 51: 7216-7233 [PMID:18954042] |
ChEMBL | Inhibition of [3H]CP-55940 binding to human recombinant CB2 receptor in CHO cells | B | 6.54 | pIC50 | 290 | nM | IC50 | J Med Chem (2006) 49: 7584-7587 [PMID:17181138] |
ChEMBL | Inhibition of cannabinoid CB2 receptor | B | 6.54 | pIC50 | 290 | nM | IC50 | J Med Chem (2010) 53: 4028-4037 [PMID:20423086] |
ChEMBL | Displacement of [3H]CP-55940 from recombinant human CB2 receptor expressed in CHO cell | B | 6.55 | pIC50 | 285 | nM | IC50 | Bioorg Med Chem Lett (2009) 19: 5195-5199 [PMID:19632830] |
Kv11.1/HERG in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL240] [GtoPdb: 572] [UniProtKB: Q12809] | ||||||||
ChEMBL | Inhibition of human ERG at holding potential of -80 mV to +40 mV | B | 4.85 | pIC50 | 14200 | nM | IC50 | Bioorg Med Chem (2010) 18: 6377-6388 [PMID:20673729] |
ChEMBL data shown on this page come from version 34:
Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]